-
Mar 12, 2021, 11:19 AM
by
User Not Found
Bio-IT World | Top COVID-19 news and research stories of the week: new variants will evade antibodies, inconsistencies in the Pfizer-BioNTech vaccine batches, and a new COVID Antibody Epitope Mapping service.
Full story
-
Mar 10, 2021, 10:11 AM
by
The MDI Biological Laboratory will collaborate with the Maine Center for Disease Control and Prevention, an office of the state Department of Health and Human Services, on a five-year grant from the federal Centers for Disease Control and Prevention (CDC), to improve access to safe drinking water in Maine.
Full story
-
Mar 10, 2021, 10:11 AM
by
Shimmer’s Verisense platform can now measure clinical trial participants’ heart rate, oxygen saturation and emotional responses in addition to their activity and sleep levels.
Full story
-
Mar 10, 2021, 10:11 AM
by
Full story
-
Mar 10, 2021, 10:11 AM
by
Compugen selects Dotmatics’ cloud-based LIMS and ELN solution to drive efficient drug discovery
Agreement marks the first implementation of Dotmatics SaaS technology in Israel, further extending global access
Full story
-
Mar 10, 2021, 10:11 AM
by
Integrated DNA Technologies (IDT) has launched its rhAmpSeq™ CRISPR Analysis System, which offers an end-to-end solution for characterizing and quantifying the full array of on- and off-target genome editing events in CRISPR research projects.
Full story
-
Mar 10, 2021, 10:10 AM
by
AARDEX Group, the world leader in medication adherence solutions, continues to build up its ecosystem and to bridge GMP to GCP world in Clinical Trials by reinforcing their strategic partnership with Schreiner MediPharm, a global specialist in innovative functional labels and smart packaging solutions for the pharmaceutical industry.
Full story
-
Mar 10, 2021, 10:10 AM
by
Full story
-
Mar 10, 2021, 10:10 AM
by
VERICHEM LABORATORIES has announced that the open vial stability claim on its combined Ammonia/Iron Standard Kit has been extended to an exceptional twenty-four (24) months, making it ideal for numerous calibration verification events, or test system troubleshooting.
Full story
-
Mar 10, 2021, 10:10 AM
by
Regulatory Affairs experts, G&L Scientific, have announced further expansion in Europe with new dedicated client services in Spain, Italy, Germany and France.
Full story
-
Mar 10, 2021, 10:10 AM
by
Full story
-
Mar 10, 2021, 10:10 AM
by
SB3000 is to receive grant funding from the Danish Innovation Fund to support its continuous manufacturing enabling technology for medicine production.
Full story
-
Mar 10, 2021, 10:05 AM
by
Standigm, a leading AI-based drug discovery company, raised $44.5 M in a Pre-IPO round to go public on the Korea Exchange later in 2021.
Full story
-
Mar 9, 2021, 01:00 AM
by
User Not Found
Bio-IT World | The foundation of a data commons is the data dictionary—the map or model populated with all of the data within an organization and the relationships between them. The hardest part of FAIR is the “I”—interoperability, says Bill Van Etten, senior scientific consultant at BioTeam. The data dictionary is what brings you from FAR to FAIR.
Full story
-
Mar 8, 2021, 01:00 AM
by
User Not Found
Bio-IT World | New products and company updates from around Bio-IT including Seven Bridges’ partnership with Pfizer, Illumina’s Russian approval, new methylation detection platform from Twist, and more.
Full story
-
Mar 5, 2021, 01:00 AM
by
User Not Found
Bio-IT World I Variant that emerged in the UK could be more transmissible, SARS-CoV-2 may be particularly attracted to blood group A respiratory cells, a balanced T cell response is key to clearing virus without symptoms, and out-of-place large bone marrow cells responsible for brain fog. Plus: Heart muscle cells a target and could lead to cell death, interfere with heart muscle contraction and MIS-C patients have highly activated immune systems that are similar to adult COVID-19 patients.
Full story
-
Mar 4, 2021, 01:00 AM
by
User Not Found
Bio-IT World | A host of sponsors and vendor companies attended the virtual AGBT General Meeting this week. Through sponsored talks and even more poster sessions, vendor companies shared their latest work and technology developments and made product announcements.
Full story
-
Mar 3, 2021, 01:00 AM
by
User Not Found
Bio-IT World | Neville Sanjana from the New York Genome Center and NYU turned his attention to COVID-19 early in the pandemic. For several years, his lab has focused on using CRISPR to identify which regions of the genome drive disease. Last year, he applied that expertise to using genome-wide CRISPR screens to look for COVID-19 risk factors.
Full story
-
Mar 2, 2021, 14:37 PM
by
User Not Found
Bio-IT World | Our current version of the human reference genome does not adequately represent genetic diversity in the human population, Karen Miga told the virtual audience at this week’s AGBT General Meeting. The Human Pangenome Reference Consortium and the Telomere-to-Telomere Consortium are working to change that.
Full story
-
Mar 1, 2021, 16:51 PM
by
User Not Found
Bio-IT World | Josh Denny, CEO of NIH’s All of Us program, gave an update on the population sequencing program in the opening session of the virtual AGBT General Meeting this week.
Full story